DUPHAT 2026 Speakers

Dr. Barry A. Bleidt

Barry A. Bleidt, PhD, PharmD, RPh, FAPhA Adjunct Professor, Economic, Social, & Administrative Pharmacy Division College of Pharmacy and Pharmaceutical Sciences | Institute of Public Health | USA

Adjunct Professor, Economic, Social, & Administrative Pharmacy (ESAP) Division College of Pharmacy and Pharmaceutical Sciences | Institute of Public Health at Florida A&M University. He received his BS Pharmacy from the University of Kentucky, PhD in Pharmacy Healthcare Administration from the University of Florida, and his PharmD from Xavier University of Louisiana. Barry has over forty years of professional experience in preventing drug use problems and substance misuse, looking at quality and advanced Pharmacy services, and looking towards the future of the profession. Dr. Bleidt served six years as Chair of the Program Committee for the Pharmacy Section of the American Public Health Association and fourteen years for the Alcohol, Tobacco, and Other Drugs Section, twenty-three years as the parliamentarian of the American Association of Colleges of Pharmacy, and twenty-one years as the Director of Continuing Pharmacy Education for the National Pharmaceutical Association. He has served as a Delegate to the United States Pharmacopoeia Convention from 1985 to 2020. Dr. Bleidt has also serves as the CEO of the Practicing Pharmacists Institute, Inc., an ACPE-accredited organization He has developed and administered Advanced Practice Certificate Programs and has been involved with the Immunization Certification Training of over 1,500 pharmacists, pharmacy technicians, and student pharmacists. Dr. Bleidt is the current Deputy Editor of the Elsevier Journal, Currents is Pharmacy Teaching and Learning. He delivered over 400 presentations and has been the Keynote Speaker at several International Conferences, including the Risk Behavior Research in International Settings Conference and DUPHAT. He published over fifty articles and book chapters. Some of his publications include the books: Clinical Research in Pharmaceutical Development, Multicultural Pharmaceutical Education, and A Guide to the Top 200 Drugs. Dr. Bleidt received the Lifetime Achievement Award from the Pharmacy Section of the American Public Health Association. (2021) He was inducted as a Fellow into the APhA Academy of Pharmaceutical Research and Science in 2015. He received the 2013 Chauncey I Cooper Award (the highest honor bestowed by NPhA), 2007 Award for Innovative and Exemplary Contributions to the NPhA Foundation, the Ilene B. Stiff Local Association President’s Award as the leader of the Virginia Pharmacists Association Local Association of the Year (2001), the James M. Tyson Award (2nd Highest Honor from NPhA (2001); and the American Public Health Association Leadership Award from the Alcohol, Tobacco, and Other Drugs Section (2000). He currently resides in Ft. Lauderdale, Florida."

Dr. Dominik Thor

President & Professor of Pharmacy Geneva College of Longevity Science | Switzerland

Dominik Thor is the President of the Geneva College of Longevity Science (GCLS), the world’s first higher education institution dedicated exclusively to the study of longevity science. A leading authority in longevity education and an internationally recognized speaker on longevity innovation, technology, and policy, he is at the forefront of shaping the academic and strategic future of this emerging discipline. He serves as Chair of the GCLS Semester Symposium, a leading international conference connecting experts and institutions from Europe, Asia, and the GCC, and as Co-Chair of several scientific events focused on advancing the standards and practice of longevity medicine worldwide. In his academic capacity, Dominik oversees the medical and executive education programs at GCLS and serves as Professor of Pharmacy. He is also a Visiting Professor at the University of Medicine and Pharmacy “Carol Davila” (UMFCD), contributing to the advancement of Gerontology, Geriatrics, and Longevity Medicine. An active contributor to the academic discourse, Dominik writes scientific articles on longevity education, policy, and innovation. With a research background in biomaterials, regenerative medicine, and pharmaceutical sciences, he has authored numerous peer-reviewed publications and holds multiple patents in Europe and the United States related to cell regeneration and aesthetic science.

Prof. Joseph T. DiPiro

Professor Emeritus School of Pharmacy, Virginia Commonwealth University" | USA

Dr. DiPiro received his B.S. in Pharmacy (Honors College) from the University of Connecticut and Doctor of Pharmacy from the University of Kentucky. He completed a residency at the University of Kentucky Medical Center and a fellowship in Clinical Immunology at Johns Hopkins University. He served on the Faculty of the University of Georgia College of Pharmacy for 24 years, as Executive Dean at the South Carolina College of Pharmacy from 2005 to 2014 and Dean at Virginia Commonwealth University from 2014 to 2022. He is Past-President of the American Association of Colleges of Pharmacy and Past Chair of the Council of Deans. He has served as President of the American College of Clinical Pharmacy. He is a Fellow of the College and has served on the Research Institute Board of Trustees. He has been a member of the American Society of Health-System Pharmacists, having served on the Commission on Therapeutics and the Task Force on Science. Dr. DiPiro was elected a Fellow in the American Association for the Advancement of Science. At present, Dr. DiPiro is serving as a Consultant to ACPE for the International Services Program. Dr. DiPiro was editor for Pharmacotherapy: A Pathophysiologic Approach for 12 editions, and the ASHP Pharmacy Forecast for 6 years. He served as Editor of The American Journal of Pharmaceutical Education for 12 years. He is also the author of Concepts in Clinical Pharmacokinetics and Editor of the Encyclopedia of Clinical Pharmacy. He has published over 250 journal papers, books, book chapters, and editorials in academic and professional journals"

Prof. Peter J. Pitts

Peter Pitts is President of the Center for Medicine in the Public Interest, a Visiting Professor at the University of Paris Medical School, an Honorary Proff. at Sefako Makgatho Health Scienc | USA

Peter Pitts is President of the Center for Medicine in the Public Interest, a Visiting Professor at the University of Paris Medical School, an Honorary Professor at Sefako Makgatho Health Sciences University (Pretoria, South Africa), and a Research Fellow at the US-Israel Education Association. He is a former member of the United States Senior Executive Service and Associate Commissioner of the US Food & Drug Administration.  Pitts is a member of the Council for International Organizations of Medical Sciences (CIOMS) Expert Working Group to help advance patient involvement in the development and safe use of medicines and a member of the United States Pharmacopeia Drug Shortage Task Force. He is the author of many peer-reviewed articles appearing in publications including the Lancet, Health Affairs, Journal of the American Medical Association, NEJM Catalyst, Vaccines, Nature Biotechnology, Therapeutic Innovation and Regulatory, and the Journal of Commercial Biotechnology. He is an Associate Editor of Therapeutic Innovation & Regulatory Science (the official DIA journal), a member of the Editorial Advisory Board Journal of Commercial Biotechnology and The Patient Magazine. Pitts lives in New York City. His comments and commentaries on health care policy issues regularly appear in The New York Times, The Los Angeles Times, The Washington Post, The Wall Street Journal, The Financial Times, Health Affairs, Time, Newsweek, The Boston Globe, The Washington Times, The Chicago Tribune, The San Francisco Examiner, Investor’s Business Daily, The Baltimore Sun, The Economist, The Lancet, Nature Biotechnology, BioCentury, The Journal of Commercial Biotechnology, the BBC World Service, Fox News, CNBC, Bloomberg, The PBS NewsHour, NBC Dateline, Sky News, La Stampa. L’Opinion, The Daily Show with John Stewart, among others. He has given healthcare policy presentations throughout Europe, Canada, and the United States, as well as in Russia, China, Hong Kong, Taiwan, India, the Philippines, Malaysia, Saudi Arabia, Lebanon, Oman, Israel, Turkey, The United Arab Emirates, Kuwait, Qatar, Jordan, Kenya, South Africa, Egypt, Algeria, Ukraine, Thailand, Japan, Brazil, Mexico, Vietnam, Indonesia, Singapore, Panama, Costa Rica, Argentina, and Colombia. His new book, Prescient and Possible, focuses on the need to stand firm on the urgency of sound science. He is also the author of And Nothing but the Truth, The Next Normal, The Value Equation: A Journey Through the Innovation Ecosystem in the Time of COVID, Common-Sense Healthcare for Common Sense Americans, and Become Strategic or Die, widely recognized as a cutting- edge study of how leadership, in order to be successful over the long term, must be combined with strategic vision and ethical practice. He is the editor of Coincidence or Crisis, a discussion of global prescription medicine counterfeiting and Physician Disempowerment: A Transatlantic Malaise. "

Dr. Abeer AlTeneiji

President of the Emirates Lifestyle & Longevity Medicine Society | United Arab Emirates

.

Prof. Abeer Al-Ghananeem

B.Sc. Pharm, M.Sc., Ph.D | United Arab Emirates

Professor Abeer Al-Ghananeem, Ph.D., is a distinguished academic leader and global expert in pharmacy education, research, and innovation. She currently serves as Dean of the College of Pharmacy and Health Sciences at Ajman University in the United Arab Emirates, where she oversees three professional healthcare programs (Pharmacy, Nursing, and Physiotherapy), and champions educational excellence, interprofessional training, and the integration of emerging technologies, including artificial intelligence, into health sciences education Professor Al-Ghananeem is an Academic Leadership Fellow (ALFP) of the American Association of Colleges of Pharmacy (AACP) and a Past Chair and Commissioner of the Accreditation Council for Pharmacy Education (ACPE) International Services Program. She also serves on the Board of Trustees of the Talal Abu-Ghazaleh University College for Innovation (TAGUCI) in Jordan and is Global Lead for Quality Assurance at the International Pharmaceutical Federation (FIP). Additionally, she is an Associate Editor of the FIP Pharmacy Education Journal. She has held faculty and leadership roles at the University of Kentucky and Sullivan University, USA, before joining Ajman University. An influential contributor to national and international initiatives that bridge education, healthcare, and innovation, Professor Al-Ghananeem has led projects focused on continuous professional development and interprofessional education and has helped prepare faculty and students for the transformation of healthcare in the digital age, including the strategic integration of artificial intelligence in healthcare education and assessment.

Mr. Adam Wolf

Technology executive, | United Arab Emirates

Adam Wolf is a technology executive, entrepreneur and investor with nearly 20 years of experience building and scaling technology businesses across the UK and Middle East. He spent more than 15 years with BIOS Middle East, ultimately becoming Managing Director and playing a key role in growing the business and its sovereign cloud platform, CloudHPT. Following BIOS’s acquisition by ZainTECH, Adam became Chief of Cloud Services, leading cloud strategy and operations across the region. Today, Adam is Co-Founder of Nexian, an AI governance company helping organisations build, automate and govern AI safely at scale. He is also COO and Board Member of The Ten Percent Club and an active investor and advisor across technology and emerging businesses. Adam combines deep technology expertise with a strong commercial and operational track record, specialising in building teams, taking complex technologies to market and scaling businesses across multiple geographies.

Dr. Afroz Azam

Head of IT | United Arab Emirates

The Body Shop | Subway | KOJ Interiors

Dr. Ahmed Kamel

Head of Supply Chain | United Arab Emirates

Head of Demand & Supply chain at Al Khayyat Investments (AKI)

Dr. Ahmed Elzayat

Professor of Rheumatology, UAE | United Arab Emirates

.

Dr. Alaaeldin Bashier

Consultant Endocrinologist, | United Arab Emirates

20+ years of clinical experience, Clinical Professor of Endocrinology at MBRU and active academic contributor FRCP, FACE, MSc (Diabetes, Cardiff) with strong specialization in diabetes and metabolic disorders Recognized researcher with extensive publications and contributions to regional and international guidelines Scientific Committee Member – EDEC, actively shaping regional endocrinology discourse Experienced international speaker with expertise in diabetes management, cardiometabolic health, and endocrine research.

Dr. Ali AlTahoo

Regulatory Affairs Pharmacist and Drug Manufacturing Site Inspector at the National Health Regulatory Authority (NHRA) in the Kingdom of Bahrain" | Bahrain

Dr. Ali Ahmed AlTahoo is a Regulatory Affairs Pharmacist and Drug Manufacturing Site Inspector at the National Health Regulatory Authority (NHRA) in the Kingdom of Bahrain. His role at NHRA comes after graduating from the University of Bahrain with a Bachelor of Science in Pharmacy and gaining holistic insights on the local pharmacy field and the challenges posed in its practice through volunteering during the COVID-19 pandemic in Bahrain’s government hospitals, and formerly working as a community pharmacist. In his current role, he contributes to the oversight and regulation of pharmaceutical products and manufacturing facilities, ensuring compliance with national and international standards to safeguard public health. Ali’s responsibilities extend across a wide range of regulatory functions, including the assessment, licensing, and post-registration surveillance of medicines. He is experienced in all the processes of registering pharmaceutical products: new registration, medicine variations, and medicine license renewals. Ali also conducts local and international Good Manufacturing Practice (GMP) inspections, evaluating pharmaceutical manufacturing sites to ensure adherence to quality, safety, and e3icacy requirements. His inspection work is guided by globally recognized frameworks such as those established by the World Health Organization, the European Medicines Agency, and the Gulf Health Council. Ali aims to continuously contribute to the advancement of NHRA’s mission to enhance the quality and reliability of healthcare services in Bahrain. He has also supported the implementation of digital transformation initiatives, contributing to the development and optimization of NHRA’s electronic platform for regulatory processes related to pharmaceutical products, Adweya, designed to improve e3iciency, transparency, and stakeholder engagement across the healthcare sector. Alongside Ali’s progression in his role as a regulatory a3airs pharmacist and inspector, he is committed to his role in advocacy for pharmacists in Bahrain, with numerous scientific and societal contributions to the pharmacy sector. His contributions are mostly reflected through the Bahrain Pharmacists Society, the main body representing pharmacists in Bahrain. Ali began as a member of the society and recently advanced to its board of directors as the financial secretary. He is one of the main contributors to creating and organizing the society’s annual BAPHCON conference in Bahrain, now serving as a podium for pharmacists in the GCC region to share their knowledge and experiences"

Prof. Ali Abdullah

MPharm, MSc Head of TPN Unit, Mubarak Al-Kabeer Hospital Kuwait Pharmaceutical Association Board Member Visiting Teaching Assistant, College Of Health Science, PAAET | Kuwait

Prof. Ali Abdullah serves as the Head of the Total Parenteral Nutrition Unit in the Pharmacy Department at Mubarak Al-Kabeer Hospital, one of Kuwait’s largest and most prominent medical facilities, catering to a population exceeding 250,000. He has led teams within the department, including participation in scientific and quality control committees. RPh. Abdullah is also serving now as Board member of Kuwait Pharmaceutical Association. Additionally, he holds a position as a visiting teaching assistant in the Department of Pharmaceutical Science at the College of Health Sciences, Public Authority of Applied Education and Training. He has contributed to editing the "200 Common Drugs of Kuwait" booklet, recognized as one of the country's latest pharmaceutical references, and has co-authored several articles in collaboration with Kuwait University. RPh. Abdullah holds an MSc from King's College London, a globally renowned school of pharmacy

Dr. Ali Saleh Al Younis

Clinical Pharmacist in Internal Medicine at King Faisal General Hospital, Al-Ahsa | Saudi Arabia

Dr. Ali Saleh Al Younis obtained his Doctor of Pharmacy degree in 2013 and completed his PGY-1 Pharmacy Residency in 2021, followed by a PGY-2 in Internal Medicine at King Khalid Medical City. He currently serves as a Clinical Pharmacist in Internal Medicine at King Faisal General Hospital, Al-Ahsa. Dr. Al Younis is a Board-Certified Pharmacotherapy Specialist (BCPS) with a strong focus on antimicrobial stewardship, therapeutic drug monitoring, and evidence-based clinical practice. He has served as a speaker and moderator in multiple national scientific conferences and is dedicated to advancing clinical pharmacy practice, research, and education across Saudi Arabia.

Dr. Amal Yaakoub

Quality Manager, National Reference Laboratories (NRL) | United Arab Emirates

Dr. Amal Yaakoub is the Quality Manager at the National Reference Laboratories of the Emirates Drug Establishment, where she leads quality, compliance, and laboratory excellence initiatives supporting the regulatory testing and quality assessment of pharmaceutical and healthcare products.  With more than 20 years of experience across the pharmaceutical industry and government sectors, her expertise spans pharmaceutical quality control, analytical testing, method validation and verification, technology transfer, stability assessment, quality systems, data integrity, computerized system validation, and ISO/IEC 17025 laboratory management. Her current work includes strengthening national laboratory capabilities for the assessment of complex and emerging medicinal products, including biologics, biosimilars, vaccines, and advanced therapies, with a focus on regulatory science, risk-based quality oversight, and internationally recognized laboratory standards.   Dr. Yaakoub is an ISO 9001 Lead Auditor, experienced in ISO/IEC 17025 laboratory quality systems, and a member of the International Society for Pharmaceutical Engineering (ISPE). She also serves as a member of the Biotechnology Advisory Council at the American University of Ras Al Khaimah (AURAK).   Her professional interests include advancing pharmaceutical quality and regulatory science through innovative analytical approaches, laboratory digitalization, data integrity, and the responsible adoption of emerging technologies in regulated environments.

Dr. Amr Saad

BSc. Pharm, MSc, PhD. CEO, VigiHub consultancy agency Former WHO pharmacovigilance consultant Former Associate Minister of Health for Pharmaceutical Affairs Senior Clinical Lecturer in severa | United Arab Emirates

"Dr. Amr Saad is a globally recognized expert in pharmacovigilance, regulatory affairs, and strategic health governance, with over 26 years of leadership across Egypt and the Arab region. He holds a PhD in Epidemiology from the University of Manchester and has participated in over 260 national and international conferences, publishing extensively in PubMed-indexed journals. As the founding head of the Egyptian Pharmaceutical Vigilance Center (EPVC), Dr. Saad built Egypt’s national PV infrastructure from the ground up—establishing SOPs, ADR databases, WHO-UMC integration, and a nationwide yellow card system. He led national PV audits to evaluate system integrity, regulatory compliance, and risk-based performance across MAHs and healthcare institutions. He also spearheaded awareness campaigns, curriculum integration across 12 universities, and regulatory mandates requiring PV departments in all MAHs. Dr. Saad served among the main consultants for the establishment of the Egyptian Drug Authority (EDA), leading the adoption of CTD/eCTD, pricing reforms, and drafting Egypt’s Strategic Health Map 2030. As Associate Minister of Health, he oversaw pharmaceutical sector reform, essential medicines lists, SSFFC countermeasures, and crisis management protocols. Regionally, he chaired the Arab League’s Higher Technical Committee for Medicines, authoring the Common Arab Guidelines for Pharmacovigilance and Bioequivalence, approved by Arab Ministers of Health. His harmonization efforts shaped cross-border regulatory alignment and institutional capacity-building. Dr. Saad also serves as a strategic consultant to multinational pharmaceutical companies, providing expert guidance to strengthen and optimize their pharmacovigilance infrastructures. He is the Founder and CEO of VigiHub® Consultancy and Training Agency, delivering over 460 workshops and training 15,000+ professionals across 20+ countries in PV, pharmacoepidemiology, and regulatory systems. His academic leadership spans multiple Egyptian universities, where he developed Pharm D, MSc, and PhD programs, PV diplomas (Cairo & Sharjah), and supervised over 15 postgraduate theses. Dr. Saad is a WHO consultant focused on integrating PV functions at hospital levels and launching nationwide TOT campaigns. He serves on national ethics boards, clinical pharmacy fellowship committees (MOH & Military), and the ruling board of CRC-TBRI. His contributions to herbal clinical trial guidelines, curriculum evaluation, and regulatory audits position him as a strategic force in global drug safety and regulatory science"

Dr. Anas Hamad

Director of Pharmacy Department at Qatar's National Center for Cancer Care & Research. He is the Head of Medication Safety & Quality Center and Head of Pharmacy Research Center at Hamad Medi | Qatar

Dr. Anas is currently the Director of Pharmacy Department at Qatar's National Center for Cancer Care & Research. He is the Head of Medication Safety & Quality Center and Head of Pharmacy Research Center at Hamad Medical Corporation's Pharmacy Executive Office. He holds a position at Qatar University as a Clinical Associate Professor of Clinical Pharmacy & Practice. He is chairing the Standing Committee on Medication Services at Qatar Red Crescent Society. He is also the Vice President & Director of ISPOR Qatar Chapter. In addition, he is leading the Health Technology Assessment and Innovation Regulation Project under the National Health Strategy in the Ministry of Public Health. Dr. Anas finished his BSc in Pharmacy at the University of Jordan. He obtained MSc in Clinical Pharmacy, International Practice & Policy from the University of London and PhD in Clinical Practice & Medication Use from King's College London. He also acquired an Executive Diploma in Health Services Management from GSM London. Furthermore, he completed the Executive Leaders Program with Qatar Leadership Centre. That is in addition to multiple postgraduate certificates in health technology assessment, supply chain management, human subjects research, quality management, health economics and outcomes research. Dr. Anas is an active researcher with several publications and conference proceedings. He is an Editorial Board Member at International Journal of Clinical Pharmacy and Review Editor at Frontiers in Oncology. He regularly speaks at local and international conferences. He is a member of both HMC's and QU's Institutional Review Boards in addition to the MOPH National Clinical Research Review Committee. Moreover, he is a member of various committees/boards focusing on pharmacy practice, medication use, cancer care, research, safety & quality, medical affairs, healthcare education, health economics, governmental tenders, clinical transformation, and health insurance"

Dr. Angela Thomas

Founder & Strategic Director | United Arab Emirates

Healthcare Growth Strategist | Entrepreneur | Business Development Executive | Author

Dr. Aqila Mohammed Hassan Taqi

Consultant pharmacist at Sultan Qaboos University Hospital- pharmacy department | Oman

Dr. Aqila Mohammed Hassan Taqi is a consultant pharmacist at Sultan Qaboos University Hospital- pharmacy department. She has over 15 years’ experience in clinical pharmacy practice, as a clinical pharmacist for paediatrics and bone marrow transplantation services and more recently in neonatal and paediatric critical care services. Aqila was also the pharmacy’s quality representative since 2010 and coordinated the department’s accreditation preparedness activities for both ISO 9001 certification and later on for Accreditation Canada International (ACI) certification at SQUH . Dr. Aqila pursued her PhD in pharmacoepidemiology and clinical pharmacy from the University of Nottingham –UK in July 2020. Her research was on analgesics’ safety in primary care patients in UK, for which she used data from the clinical practice research datalink, one of world’s largest medical records databases. Upon her return, she was honoured by Oman’s first lady her highness Sayedah Ahd Bint Abdulla on the country’s women’s day for her contribution to the nation’s progress She has special interest in clinical pharmacy practice and safe use of medications and her work was published in a number of peer reviewed scientific journals."

Dr. Baref Zahir Rashid

Assistant Professor of Pharmacology - Head of Syndicate of Kurdistan Pharmacists-Iraq (SKPI) | Iraq

President, Kurdistan Pharmacy Summit – Erbil (2021) • President, Iraq/Kurdistan Pharmacy Summit – Sulaimaniyah (2022) • President, First National Conference on Combating Microbial Resistance Against Antibiotics and Development of Pharmacovigilance in the Kurdistan Region (2023). • President, Pharmacist summit (2024). • President, PharmaDev Conference (2025) , Lecturer, Pharmacy Department, Sulaimani Technical Institute, Sulaimani Polytechnic University (September 2009 – March 2010) • Head of Pharmacy Department, Sulaimani Polytechnic University (March 2011 – September 2021) • Assistant Professor of Pharmacology (2025 – Present) • Member, Kurdistan Higher Council for Medical Specialties (KHCMS) (2024 – Present)"

Dr. Basem Al Barahmeh

CEO | United Arab Emirates

25+ years plus experienced CEO, expertises in pharma manufacturing, Sales, Marketing and commercial operations along with P&L management. proven track record in established brands & new launches, expertise in pre-license sales of specialty pharmaceuticals for Oncology, Hematology, transplantation and rare diseases along with primary care brands and branded generics in both private and governmental sectors. Experience in Middle East and Africa with exposure to international markets.

Dr. Bassam Attalah

Perioperative Cardiac Surgery Medication Management | United Arab Emirates

Dr Atallah is the Associate Dean for Clinical Affairs at Dubai Medical University. Prior to joining DMU he served as Cardiovascular Senior Pharmacotherapy Specialist at Cleveland Clinic Abu Dhabi and Clinical Associate Professor at Cleveland Clinic Lerner College of Medicine. Prior to joining Cleveland Clinic he was on faculty as Assistant Professor of Clinical Pharmacy at King Saud bin Abdulaziz University for Health Sciences (KSAU-HS) in Riyadh. Dr. Atallah received his PharmD from Bernard J. Dunn School of Pharmacy in Virginia and completed an ASHP accredited post graduate residency at Winchester Medical Center in Virginia. He was awarded the “Graduate of the Last Decade” award by his alma mater. Dr. Atallah is board certified in pharmacotherapy with added qualifications in Cardiology. He also holds an advanced antithrombotic management certificate from ASHP. Dr Atallah is a fellow of the Heart Failure Society of America (HFSA) and the American College of Clinical Pharmacy (ACCP). He has several publications and presentations at national and international conferences. He was awarded the 2021 ACCP Cardiology PRN international award. His research interests are in various aspects of cardiovascular pharmacotherapy with focus on antithrombotic therapy, heart failure and hyperlipidemia."

Dr. Bassam Mahboub

Head of Pulmonary Medicine | United Arab Emirates

Dr. Bassam Mahboub is a distinguished pulmonologist, allergist, researcher, and healthcare innovator based in the United Arab Emirates. He currently serves as Head of Pulmonary Medicine at Rashid Hospital, Dubai Health Authority (DHA), a position he has held since 2007, and is a Clinical Professor at the University of Sharjah Faculty of Medicine. Dr. Mahboub completed his medical degree at UAE University and pursued advanced training in Canada, earning certification from the American Board of Internal Medicine, American Board of Pulmonary Medicine, and American Board of Allergy and Clinical Immunology, alongside fellowships from the University of British Columbia and the University of Toronto. He also holds an MBA from the University of Wolverhampton, UK, and is certified in Lean Six Sigma. Recognized as a leader in healthcare innovation, Dr. Mahboub played a pivotal role in developing the Dubai Health Authority's Innovation and Artificial Intelligence Strategy and founded the Dubai Health Innovation Centre (DHIC). He has held several key leadership positions, including Assistant Dean of the University of Sharjah Medical College, Program Director for Care Model Innovation at DHA, and Head of the Emirates Allergy and Respiratory Society. A prolific researcher and editor, Dr. Mahboub has authored and co-authored more than 50 scientific publications and book chapters focusing on asthma, allergy, respiratory diseases, sleep medicine, tuberculosis, COPD, and artificial intelligence in healthcare. His research has attracted significant international funding and has contributed to advancing respiratory medicine across the Middle East and globally. For his clinical excellence, research achievements, and innovation leadership, Dr. Mahboub has received numerous prestigious awards, including the Mohamed Bin Rashid Innovative Employee Award (2021), the UAE Ideas Competition Award (2019), and multiple Dubai Health Authority Distinguished Physician, Researcher, and Innovation Awards. Dr. Mahboub's career reflects a commitment to improving patient care, advancing respiratory science, fostering medical education, and driving healthcare transformation through innovation and technology.

Dr. Belal Hamed

Senior specialist pharmacist | United Arab Emirates

.

Dr. Christian Wölbeling

Founder & Chair of the ISPE CoP Leadership Team | United Arab Emirates

Introduction to ISPE – shaping the future of pharma together with EDE in UAE

Dr. Ehsan Habeeb

Cardiology Consultant Clinical Pharmacist Taibah University – College of Pharmacy | Saudi Arabia

"Dr. Ehsan Habeeb is a Cardiology Consultant Clinical Pharmacist and Assistant Professor at Taibah University – College of Pharmacy, where he also serves as the Director of the Alumni Center and the Head of the Pharmacy Practice Department. He completed his Post‑Graduate Year 1 (PGY1) Pharmacy Residency and Post‑Graduate Year 2 (PGY2) Cardiology Residency at Massachusetts General Brigham, a Harvard Medical School–affiliated institution in Boston, United States. He further advanced his expertise through a Fellowship in Cardiology Pharmacotherapy and Clinical Research at the same institution. Dr. Habeeb is Board Certified Pharmacotherapy Specialist (BCPS), a Board Certified Cardiology Pharmacist (BCCP), and a Certified Anticoagulation Care Provider (CACP). With a strong foundation in cardiovascular pharmacotherapy, Dr. Habeeb is recognized for his contributions to clinical practice, patient safety, and guideline-driven care. His clinical expertise spans heart failure, arrhythmias, anticoagulation, and complex cardiovascular pharmacotherapy—supporting evidence-based decision‑making in both acute and chronic care settings. He has authored and co‑authored numerous peer‑reviewed publications in international journals and actively supervises several clinical and academic research projects in cardiology, anticoagulation, and medication‑related outcomes. As Head of the Pharmacy Practice Department at Taibah University, Dr. Habeeb has led several initiatives aimed at elevating the quality of pharmacy education and advancing clinical pharmacy practice. His efforts include curriculum enhancement to align with global accreditation standards, expansion of experiential training sites, development of structured clinical rotations, and the integration of research and simulation‑based learning into student training. He works closely with local healthcare institutions to strengthen hospital–university collaborations, support pharmacist workforce development, and enhance patient-centered care models across the region. Through his extensive clinical experience, academic leadership, and continuous pursuit of innovation in pharmacy practice, Dr. Habeeb plays a pivotal role in advancing clinical pharmacy and cardiovascular care both in Saudi Arabia and across the Middle East. His collaborative efforts with clinical pharmacists from various Gulf countries and healthcare institutions have contributed to the development of regionally-relevant practices, training standards, and research initiatives aimed at elevating the quality of pharmaceutical care."

Dr. Fakher Alayobi

B. Pharm, MSC, Rph, BHF, MBA, ABSP, PhD | Saudi Arabia

• Intensivist Cardiology Clinical Pharmacist, Head of the Cardiology Quality Pharmacy Team, department of cardiac sciences King Fahed Cardiac Center (KFCC), College of Medicine. • Adjunct Assistant Professor, College of Pharmacy, at King Saud University. • The founder and first President, of Cardio Clinical Pharmacy Group, at Saudi Heart Association • The founder of women chapter at the Saudi Pharmacy Society • Establishing as well as implementing different national guidelines, with the collaboration of MENA and Global Countries. • Lead the world’s largest international health care practitioners & health technology gathering in the pandemic era under the name of SCOPE. Dr Fakhr has a PhD & master’s degree in clinical pharmacy research as well as master’s in business administration. She is Board certified in clinical poisoning management, Heart Failure, and specialized Arab Board in Cardiology Pharmacy. Dr Alayoubi, is certified as train the trainer for metabolic syndrome (Diabetes, Cardiovascular Disease) from the American Pharmacy Association APhA, Meddle East Representative (EMRO) for the Europe pharmacy society FIP (Foundation of International Pharmacy) for Hospital pharmacy and the leader for the global anticoagulation stewardship research, finally the founder and primary investigator of the Saudi Amyloidosis registry (SAMR).

Dr. Faris Almaazmi

Director of the Inspection and Control Department | United Arab Emirates

Faris Almaazmi is the Director of the Inspection and Control Department, with 18 years of experience in inspection, investigation, management, and human resources management. His experience includes leading GMP and GSP inspection activities, regulatory oversight, team management, and the development of inspection practices and processes. 

Dr. Fathea Adheir

Director of Pharmacy at Sidra Medicine | Qatar

Fathea Adheir is the Director of Pharmacy at Sidra Medicine in Doha, Qatar, with over 23 years of experience in hospital pharmacy and healthcare leadership. She holds a pharmacy degree and an Executive MBA from HEC Paris–Qatar. Ms. Adheir is recognized for her commitment to quality, patient safety, and innovation in pharmacy practice. Throughout her career, Ms. Adheir has led the implementation of advanced pharmacy automation systems and played a pivotal role in activating and managing comprehensive pharmacy services at Sidra Medicine. Her leadership has contributed to the successful launch of multiple hospital pharmacy services, and she has been instrumental in developing medication management policies and optimizing inventory processes. Ms.. Adheir is a strong advocate for patient-centered care and believes in the importance of involving patients in their treatment journey. She is also active in public health education, using social media to raise awareness about medication safety and proper usage. Her influence extends beyond Sidra, as she is a member of the MENA coalition for HPV elimination and collaborates with WHO groups on regional strategies for cervical cancer screening and prevention. Her dedication to excellence has been recognized with awards such as the Stars of Excellence from Hamad Medical Corporation for quality and patient safety. Ms. Adheir continues to contribute to the advancement of pharmacy practice through research, education, and active participation in regional and international conferences."

Prof. Fatheya Alawadi

Consultant Endocrine and Head of Endocrine department | United Arab Emirates

.

Dr. Fatma Raisi

President | Oman

distinguished clinical pharmacist, academic leader, and President of the Oman Pharmaceutical Society (OMPHS) with over 24 years of experience in nephrology pharmacotherapy, clinical pharmacy, and higher education. With a Ph.D. in Clinical Pharmacy and a strong background in leadership, stakeholder engagement, and strategic partnerships, I am committed to advancing the pharmacy profession by integrating education, research, and policy advocacy. As President of OMPHS, I have successfully led national and international collaborations with GCC pharmaceutical societies, global pharmaceutical companies, and medical and non-medical organizations in Oman. My efforts have resulted in fundraising initiatives, policy advancements, and educational collaborations that enhance pharmacy practice and public health in Oman. My strategic vision drives continuous improvement in pharmacy education, pharmaceutical regulations, and clinical practice, ensuring excellence in patient care, research, and professional development. I’m well recognized for building strategic alliances, policy advocacy, and high-impact negotiations to strengthen healthcare education and clinical practice. A strong communicator and influencer, serving as a key representative in international conferences and advisory panels which foster experience in external relations, stakeholder engagement, strategic partnerships, build high-level networks and healthcare leadership.

Dr. Fauzia Rashid

Consultant, Endocrine | United Arab Emirates

Dr.Fauzia Rashid graduated from Pakistan in 2000 with the role of honor. She is Consultant Endocrine in department of diabetes and endocrinology in Dubai hospital and clinical Associate Professor MBRU ,Dubai ,UAE. She is a clinician-researcher with extensive experience in diabetes, endocrinology, obesity, and metabolic medicine. She has contributed to large population-based studies, systematic reviews, meta-analyses, clinical guidelines, and consensus statements. She has presented her work at major international conferences, including the IDF, Endocrine Society, and Emirates Diabetes & Endocrine Congress, and remains actively involved in collaborative research networks across the Middle East and beyond.

Dr. Ghattas S.G.Abudawoud

Clinical Pharmacist | United Arab Emirates

Dr. Ghattas S. G. Abudawoud is a BCPS-certified Clinical Pharmacist with extensive experience in hospital-based and rehabilitation healthcare settings in the United Arab Emirates. He holds a Master’s degree in Clinical Pharmacy with distinction and has demonstrated a strong commitment to advancing patient-centered care through evidencebased practice. Currently serving at Erada Center for Treatment and Rehabilitation in Dubai, Ghattas has played a key role in establishing and integrating clinical pharmacy services within a multidisciplinary care model. His work includes the development of clinical workflows, implementation of automated dispensing systems, and active contribution to Pharmacy and Therapeutics Committee initiatives, including formulary management and policy development. Prior to this, he practiced at Emirates Health Services, where he was actively involved in optimizing pharmacotherapy across multiple specialties, including infectious diseases, cardiology, endocrinology, and geriatrics. His clinical expertise includes medication safety, antimicrobial stewardship, and the identification and resolution of drug-related problems. In addition to his clinical role, Ghattas is actively engaged in academia as an Adjunct Clinical Lecturer at the University of Sharjah and a Clinical Preceptor at Ras Al Khaimah Medical and Health Sciences University, where he mentors pharmacy students and contributes to experiential education and clinical training. He also serves as Cultural Committee Chairperson at the Emirates Clinical Pharmacy Society, supporting professional development initiatives and fostering engagement within the pharmacy community. Ghattas has contributed to the scientific literature with peer-reviewed publications and has participated in multiple national and regional conferences

Dr. Hesham Abdalla

Managing Director at Albatha Healthcare | United Arab Emirates

Dr. Hesham currently serves as Managing Director of Albatha Healthcare Group and Chief Executive Officer of Modern Pharmaceutical Company, where he leads the growth of an integrated healthcare platform spanning pharmaceutical and medical distribution, pharmacy networks, diagnostics, and mental health services. His leadership combines clinical expertise with strategic and commercial insight, with a focus on advancing healthcare access and delivery across the UAE and wider region

Dr. Huda Alharthi

Consultant pharmacist with over 20 years’ experience in clinical pharmacy practice | Oman

With a rich career spanning 22 years at Khoula Hospital, Muscat, Oman, Huda Al Harthy is a consultant pharmacist with over 20 years’ experience in clinical pharmacy practice. She hold MSc degree in Clinical pharmacy from Strathclyde University/ UK. She worked as head of clinical pharmacy for 17 years and acting director of pharmacy directorate in Khoula Hospital She practiced clinical pharmacy in various surgical specialties such as orthopedics and general surgery. She has been an integral member of the hospital’s Drug Therapeutic Committee, addressing complex medication-related issues and contributing to hospital-wide audits, training, and educational initiatives. Huda also being involved in developing different guidelines, policies and procedures; for example standards of clinical pharmacy practice (which highlight on the important skills needed in clinical pharmacy, these SOP being approved by the hospital quality department), OPAT service, osteoporosis national guideline and national antimicrobial management guideline. In addition to her committee roles, she has actively participated in numerous pharmaceutical events both locally and internationally, often serving as a speaker or poster presenter. Her passion for pharmacotherapy improvement and her extensive experience in clinical education have made her a respected mentor and a driving force in the continuous improvement of pharmacy practice. She has recently transitioned into Drug Safety Center, bringing her clinical pharmacy expertise into the realm of medication registration and regulatory affairs. Furthermore, she is member of Taskforce of the Central Drug Committee in Ministry of Health. "

Prof. Hussain Bakhsh

Professor of Pharmacy Practice, Consultant clinical pharmacist, Director of Pharmaceutical Services at King Abdulaziz University Hospital. " | Saudi Arabia

Prof. Hussain Bakhsh is the director of the pharmaceutical services and professor of pharmacy practice at The Faculty of Pharmacy, King Abdulaziz University. Prof. Bakhsh earned his Doctor of Pharmacy degree from King Abdulaziz University after which time he completed Pharmacy Practice Residency and Emergency Medicine Specialty Residency training at The University of Arizona. Dr. Bakhsh’s area of research includes: Emergency medicine, pharmacy practice, and pharmacy education

Dr. Hussien Heshmat Ali Kassem

Consultant interventional cardiology | United Arab Emirates

Professor Cardiology, Kasr Al-Ainy Faculty of Medicine, Cairo University (On Sabbatical leave from January 2018 till date) The cardiology department at Cairo University encompasses more than 100 cardiology beds and four cath labs across three hospitals. The cath labs perform annually >3000 diagnostic and interventional procedures. We annually publish abstracts at international conferences. In addition to the weekly volume of diagnostic and interventional coronary procedures, duties include curriculum design, undergraduate lectures, and postgraduate teaching. Associate Editor, The Egyptian Heart Journal (January 2016 till date) http://www.egyheartjournal.com/en/Produced and hosted on behalf of the Egyptian Society of Cardiology, the Egyptian Heart Journal aims to publish the highest quality material on all aspects of Cardiovascular Medicine. I ensure the quality and timeliness of the content that is published. I coordinate with the editor-in-chief the process of submission of manuscripts, assignment to reviewers, overview of decisions taken, and communication with the authors.

H.E. Ibtisam Al Saadi

Acting Assistant Undersecretary for the Industrial Development Sector | United Arab Emirates

Dynamic and highly experienced Business professional with a strong record developing, implementing and delivering on growth strategies and initiatives, including company establishment, restructures and rebrands. Influences collaboration, productivity, high performance standards and efficiencies optimization from idea generation through to implementation. Strong reputation for ability to plan, align and lead organizations through change. Exceptional communicator and negotiator with a talent for stakeholder management, customer service excellence and networking. Active participant in boards and investors planning and decision-making, as well as undertaking multiple concurrent roles and projects with companies in which board members have ownership or interests.

Dr. Isabel Afonso

Chief Executive Officer | United Arab Emirates

Global executive with broad experience in leading and transforming businesses in Private Equity, a large corporation, a start-up founding and now serves as Chief Executive Officer of Arcera life sciences, owned by ADQ - an Abu Dhabi-based investment fund. Arcera life sciences has a footprint spanning over 90 countries across four continents, 2000 branded medicines across multiple therapeutic areas with a workforce of 6500 people. Prior to that, Isabel was the Head of In-Market Brands and Business Innovation for Novartis International ($22b portfolio). Before, she was the General Manager Oncology in China, the fastest-growing market worldwide and top priority market for Novartis. Previously served as Chief Commercial Officer at Performance Health (a PE owned company), responsible for more than 100 countries with a high focus on the USA market and digital transformation. Between 2015 and 2018, Isabel served on the Sandoz Executive Committee as the Head of Global Commercial Operations, including all global franchises and Business Development, a Novartis’s $10 billion division in Munich, Germany. She held multiple business and functional leadership roles in the Novartis group (in total of 18 years). She started in the IT Pharma division, moved to Sales and Marketing in Consumer Health in 2010 and was General Manager of Switzerland and a Cluster Head within Europe before becoming part of the Sandoz executive committee. Isabel has a proven track record of leading successfully in a multi-cultural environment and delivering business results. She has high energy and great agility to learn, inspires growth, and positively disrupts teams and businesses to deliver significant impact.

Dr. Jens Krumbiegel

Senior Manager Sales & Business Consulting with focus on Middle East @ Körber Pharma - market leader for Pharma MES | United Arab Emirates

"ISPE The Digital Advantage in Pharma Production How Digitalization Enables High-Quality, Efficiency, and Regulatory Trust

Dr. Joshua Tanner

Medical doctor | United Kingdom

Dr. Joshua Tanner is a medical doctor and AI systems engineer. He received his training at Stanford, where he served as Co-Executive Director of HealthAI and taught his own graduate course, Deep Learning in Medicine. He has spent eight years in AI, building more than 30 systems across 10 countries in areas including computer vision, natural language, and graph neural networks. His work now centres on AI in regulated industry. He built a core layer of the AI agent verification engine used by enterprises such as Google, WPP, Moderna, and the UK government. Most recently he has worked with TechVolution to develop automation workflows for the pharmaceutical sector, and he is currently the Head of AI at Nexian, which builds governance and compliance infrastructure for AI and agentic workflows for regulated industries.

Dr. Khaled M.EL-Atawi

• MB.B.Ch., M.Sc. & PhD. | Egypt

• Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, EGYPT • Master Healthcare Management, Royal College of Surgeon of Ireland. • A/Consultant Neonatology, NICU, Latifa Hospital • Clinical Quality Specialist, Latifa Hospital • Lecturer of Pediatrics in Dubai Medical College • Pediatric Resident Supervisor, Latifa Hospital DHA • Regional Trainer for NRP by AAP since 2014 • STABLE Course director in Latifa Hospital • Editorial Board member of the journal “Pediatric and neonatal nursing” • Editorial Board member of Journal of Pediatrics & Neonatal Care. • President of Arab Neonatal Group and Congress • International Member in American Academy in Pediatrics. • Board member of Pediatric Arab Union. • Member in the Scientific Board of the International Academy of Neonatology. • Field of interest Neonatal Ventilation, Neonatal Nutrition, Brain injury and protection. • Working with team on quality improvement projects with positive results especially on reducing incidence of severe IVH and ROP as well.

Dr. Khlood Mustafa Catroon

Senior clinical pharmacist at Corniche Hospital, UAE | United Arab Emirates

Dr. Khlood Mustafa Catroon is a senior clinical pharmacist at Corniche Hospital, the premier maternity hospital in the emirate of Abu Dhabi. Khlood obtained both her B.Sc. and M.Sc. in pharmacy from the College of Pharmacy, Baghdad University in 1990 and 1997 respectively. Khlood is also SIDP certified and ASHP certified in Emergency Medicine and pharmacogenomics Khlood has 12 years’ work as an assistant teacher in the College of Pharmacy, Baghdad In 2008, Khlood joined Corniche hospital in Abu Dhabi Khlood has conducted research at Baghdad University in addition to her participation in many projects, audits related to quality improvement, and medication safety initiatives both at the hospital and SEHA level, in addition to her role as a Co-chair for Corniche antimicrobial stewardship program Co-chair for the hospital PTC Khlood is the silver winner at SEHA level for the QIP entitled “A Collaborative Approach to Enhancing Medication Safety in a Tertiary Neonatal Intensive Care Unit and shortlisted for IHSAN AWARD – 2021 3RD Cycle/ SEHA Allied Health Excellence Award and for 1st and 2nd SEHA Audit Award 2024 and 2025 / Patient Safety and SEHA level She is a member of a list of committees at Corniche hospital and at the level of SEHA including SEHA ASP committee where she is responsible for ASP SEHA staff educational programs She is a co-author for several published articles and participated as a Scientific committee member/speaker in a huge number of national and international conferences. She is an active board member of Emirates Clinical Pharmacy Society ECPS

Dr. Mahmoud Galal Mahmoud Ahmed

Professor of Pediatrics | United Arab Emirates

Dubai medical university Neonatology consultant -Dubai hospital

Dr. Mariam Galadari

Public Affairs and Board Advisor | United Arab Emirates

Dr. Mariam Galadari is the first Emirati women pharmacist, who established the Regulatory Department in MOHAP, as the Board Advisor for Globalpharma. •Dr. Mariam is setting a great example for Emirati women, inspiring them to pursue their passion and through her dedicated efforts, proved that Emirati women can play an important role in contributing and driving the UAE’s vision. •Dr. Mariam has contributed to the preparation of the Pharmacy Law and participated with the team in local tenders and contributed to several committees, such as the evaluation of certificates and practice, the media committee, and the inventory committees. •During her career, Dr. Mariam received many awards of appreciation. She was honored in 2016 by the Arab Pharmacists Union in Cairo, becoming the first Arab woman to receive this honor, in appreciation of her role locally and regionally in developing the pharmaceutical sector. Dr. Mariam Galadari is a distinguished figure in the realm of pharmacy and healthcare. With an illustrious career spanning years of dedicated service, she has left an indelible mark on the field. ➢As the former Director of Pharmacy and Drug Control at the Ministry of Health and Prevention (MOHAP), her leadership was pivotal in shaping pharmaceutical regulations and ensuring the safety of medications. ➢Dr. Galadari's influence extended far beyond her role, as she also held the esteemed position of President of the Pharmacist Society at the Emirates Medical Association. ➢Her expertise and insights have made her a sought-after advisor, serving on the board of a global pharmaceutical manufacturing company. ➢Notably, Dr. Galadari achieved the distinction of being the first local pharmacist to attain the role of Director of Pharmacists, a testament to her trailblazing spirit and dedication. ➢Her commitment to advancing the pharmacy profession in the UAE has earned her the endearing title of "Mother of Pharmacy" in the region. ➢An active participant on the global stage, Dr. Galadari is a member of the International Pharmaceutical Federation (FIP) and the Arab Union Pharmacy.

Mr. Martin Heitmann

B.Sc. and M.Sc. | United Arab Emirates

Martin Heitmann is a trained Business Mathematician, holding both B.Sc. and M.Sc. degrees from the University of Mannheim. Already during his studies, he specialized in optimization, probability theory and statistics. Through his first roles in consulting, he gained deep experience on data and digital technologies, including solution integration, software engineering, IT architecture and integration, data science, and reliable use of AI across industries. His expertise is augmented by project management skills, both in traditional settings as well as in agile, being a certified Professional Scrum Product Owner and Professional Scrum Master. Now with a focus in the Life Sciences, Martin fuses business acumen, technology expertise and regulatory understanding to empower life science organizations advancing their data and digital capabilities. As Managing Director of MH Consulting & Advisory GmbH, he covers various areas including Strategy and Governance, Quality Management System Transformation and Extension, AI Enablement and Upskilling, Platform Architecture and Toolset Advisory as well as Project Management, Validation Support and Regulated Company and Vendor Alignment Services. In the collaborative life science community, Martin serves in various roles, including steering committee member of GAMP® D-A-CH and Secretary of the GAMP® Global Special Interest Group Software Automation & Artificial Intelligence. He has contributed over 2 dozen publications in renowned journals, with a dedicated focus on the use of AI in GxP areas. He co-led the initiative that resulted in the landmark publication of the ISPE GAMP® Guide Artificial Intelligence, in addition to various GAMP® Good Practice Guides. Martin regularly contributes to major industry conferences, such as ISPE Annual Meetings and ISPE Europe Annual Conference, and regularly co-chairs the GAMP® D-A-CH Post-Conference on the use of Artificial Intelligence in GxP areas.

Dr. Maryam AlObaidly

PharmD., MSc., BCPS, FQS Assistant Professor at the Department of Pharmacy Practice | Kuwait

Maryam AlObaidly embarked on a transformative academic and personal journey at a young age when she left her home in Kuwait to pursue education in Ireland. As a determined and ambitious high school student entering a new educational system, she embraced a foreign culture while navigating the challenges of independence. This exciting yet demanding transition shaped her resilience and sparked a passion for pharmacy that continued to grow throughout her studies. During her early years in the Pharmacy Program at the Royal College of Surgeons in Ireland (RCSI), Dr. AlObaidly cultivated a deep appreciation for patient-centered care and the science underlying medication therapy. By her second year, her interest in pharmacology evolved from curiosity into purpose. She completed her Bachelor of Pharmacy (BPharm) degree and was selected to join a competitive Master’s research program focused on platelet activation during pregnancy, which strengthened her commitment to evidence-based clinical practice and interprofessional collaboration. Upon returning to Kuwait, she began her professional career in a variety of clinical and hospital settings. Her diligence, communication skills, and passion for mentorship quickly earned the trust of directors and clinical leaders, who encouraged her involvement in training junior pharmacists and technicians. As the healthcare landscape in Kuwait advanced toward a more clinically integrated pharmacy practice, the transition to the Doctor of Pharmacy (PharmD) curriculum at Kuwait University motivated her to pursue further education and align her capabilities with the evolving needs of the profession. She was accepted into the PharmD program at MCPHS University, an institution recognized for its strong academic networks and clinical connections with Harvard-affiliated hospitals. Throughout her advanced practice experiences, particularly in internal medicine and critical care, she refined her ability to manage complex pharmacotherapy and actively contribute to clinical decision-making. Her leadership, professional service, and commitment to advancing pharmacy were acknowledged through her induction into Phi Lambda Sigma, the Pharmacy Leadership Society, a recognition granted to outstanding leaders who demonstrate dedication to the profession. Driven by her passion for improving patient safety and optimizing therapeutic outcomes, Dr. AlObaidly completed a prestigious fellowship in the Department of Quality and Safety at Brigham and Women’s Hospital, one of Harvard Medical School’s major teaching hospitals. Her work focused on critical aspects of healthcare delivery, including medication reconciliation, pain management practices, and improving vaccination rates among vulnerable populations, while also collaborating with interdisciplinary teams on heart failure and home care initiatives. During her first year of postgraduate residency training (PGY1), she also completed the Teaching and Learning Certificate (TLS) through Northeastern University in Boston, further strengthening her pedagogical skills and commitment to pharmacy education. Her desire to expand her clinical expertise further led her to pursue a two-year subspecialty residency in Solid Organ Transplantation (PGY2) at the same institution, after which she earned Board Certification in Pharmacotherapy (BCPS). With this wealth of international training, she returned to Kuwait as a Clinical Pharmacy Specialist in the Bone Marrow Transplant unit at the Cancer Control Center. In parallel, she accepted a faculty position as an Assistant Professor at Kuwait University, where she is deeply committed to preparing future pharmacists through teaching, clinical instruction, and research mentorship. She continues to elevate pharmacy practice nationally through professional development initiatives for Ministry of Health pharmacists, including leading Medication Therapy Management (MTM) performance evaluations, delivering a Board of Specialized Pharmacy review sessions in collaboration with KUPHA, and presenting advanced Therapeutic Drug Monitoring education and evaluations to enhance clinical pharmacy capabilities across the healthcare system. In October 2025, Dr. AlObaidly’s excellence in academic mentorship and her dedication to shaping the next generation of pharmacists were recognized with the Inspiring Educator Award from RCSI’s School of Pharmacy and Biomolecular Sciences. Her journey from a young Kuwaiti student discovering her passion abroad, to a respected clinician, faculty member, and mentor reflects an unwavering devotion to advancing patient care, empowering healthcare professionals, and enriching the future of pharmacy through leadership, innovation, and lifelong learning.

Dr. Mazin Gadir

Director, Healthcare & Life Sciences | United Arab Emirates

Dr. Mazin Gadir is a Director with Alvarez & Marsal’s Healthcare and Life Sciences practice in Dubai, bringing more than 24 years of experience in healthcare innovation and digital transformation. His expertise includes digital health, health informatics, organisational transformation, eHealth regulation and healthcare technology programmes across the GCC and Middle East.

Dr. Mohamed AlBadawy

Head of Operations, BinSina Wellness & Holland & Barrett | United Arab Emirates

Mohamed AlBadawy is an experienced retail pharmacy and operations leader overseeing operations for BinSina and Holland & Barrett across the UAE and Oman. His experience spans pharmacy operations, retail management, customer experience, business strategy and operational development across multiple Middle Eastern markets.

Prof. Mohamed Baraka

Professor of Clinical Pharmacy & Former Dean of Pharmacy, FCHS , UAE. AI & Digital Health Expert. CEO, Intelligent Horizons | Saudi Arabia

"Dr. Mohamed Baraka is an internationally recognized academic leader and digital health innovator dedicated to advancing the integration of technology across healthcare and medical education. With over two decades of academic, clinical, and leadership experience across Egypt, Saudi Arabia, Belgium, and the United Arab Emirates, Dr. Baraka has been instrumental in driving digital transformation within the health sciences sector. As Associate Professor and Former Dean of Pharmacy at Fatima College of Health Sciences (FCHS), Dr. Baraka spearheaded the successful national (CAA) and international (ACPE) accreditation of the pharmacy program while embedding digital health, telehealth, AI literacy, and automation concepts into the health sciences curriculum. His initiatives have fostered interprofessional collaboration and future-ready competencies among medical, nursing, and allied health students. Globally, Dr. Baraka serves as Co-Lead of the Programme Development Working Group in the International Pharmaceutical Federation (FIP) Academic Pharmacy Section, contributing to the development of digital health and AI education programs for healthcare educators and professionals worldwide. He is also the Global AI Delegate to the UAE at the Global Alliance for Artificial Intelligence (GAFAI) and the chair of the industry cooperation & collaboration working group of GAFAI. In addition, he is an active member of the HealthAI Community of Practice, where he contributes to the evaluation and validation of AI in health and responsible AI governance frameworks. His leadership extends to the UAE National Taskforce for Interprofessional Education Framework for Healthcare Practitioners, helping shape collaborative practice standards for the country’s health education ecosystem. Dr. Baraka’s academic and professional contributions bridge clinical science, education, and digital innovation, emphasizing how AI, digital therapeutics, telemedicine, wearables, robotics, and virtual reality can enhance patient outcomes and reshape the future of healthcare delivery. He has delivered numerous keynote talks and workshops on digital transformation in healthcare and education, inspiring the next generation of clinicians to become technologically empowered and ethically grounded health professionals"

Dr. Mohamed Hassanein

Chair of DAR International Alliance/Prof of Med MBRU & Senior Endocrinologist | United Arab Emirates

.

Dr. Mohammad Fityan

Group Chief Medical Officer, Healthcare Executive | United Arab Emirates

Consultant in Internal & Obesity Medicine

Dr. Mohammed Azeez

Group Manager – Pharma |Yokogawa Middle East & Africa | Bahrain

He is a pharmaceutical digitalization and automation specialist with extensive experience supporting manufacturers across the Middle East and Africa in their Pharma 4.0 transformation journey. As Group Manager for Pharma at Yokogawa's Life Business Unit, he leads initiatives focused on manufacturing digitalization, MES, SCADA, industrial data integration, and smart manufacturing solutions. He works closely with pharmaceutical manufacturers to improve operational visibility, data accessibility, production efficiency, and compliance through innovative OT-IT integration strategies. Mohammed is a Certified MES Sales Professional with expertise in Manufacturing Execution Systems, ISA-95-based integration architectures, production data management, centralized monitoring, and enterprise manufacturing solutions. His experience spans production systems integration, manufacturing intelligence, process automation, and digital transformation programs designed to bridge the gap between shopfloor operations and business systems. He is passionate about helping pharmaceutical manufacturers create connected production environments that support operational excellence, data integrity, continuous improvement, and the broader objectives of Pharma 4.0."

Dr. Mohammed Nasser

VP& General Manager MEA | United Arab Emirates

Mohamed is the VP General Manager of Amgen in the Middle East & Africa (MEA), with over two decades of experience in the Pharmaceutical and Biotech fields in various leadership roles in strategic planning, business development and general management across Europe, Middle East & Africa. Additionally, he serves as the chairman of the pharmaceutical industry association in MEA (PHARMEA). The association contributes significantly to the industrygovernment dialogue and policy making in the region enhancing patient access to innovative medicines. Mohamed's dedication to healthcare is motivated by a commitment to support patients during their most challenging times. He is a pharmacist, holds an MBA from Bradford University UK, and a Six Sigma Black Belt. He is also a member of the board of several companies in healthcare and technology startup sectors.

Dr. Mohammed Elfar

MSc, EMBA | Regional Head of GxP Solutions – Middle East | United Arab Emirates

MSc, EMBA | Regional Head of GxP Solutions – Middle East | Körber Pharma Consulting Mohammed Elfar is the Regional Head of GxP Solutions for the Middle East at Körber Pharma Consulting, supporting pharmaceutical and biotechnology manufacturers across the GCC and wider MENA region on GxP compliance, digital transformation, AI adoption, CAPEX projects, CQV, manufacturing strategy, and technology transfer. With nearly a decade of experience in the pharmaceutical and biopharmaceutical industry, Mohammed has lived and worked across the UK, Belgium, Saudi Arabia, Jordan, and Sweden. Prior to joining Körber, he held Product & Innovation Management roles at Cytiva in the UK and Univercells Technologies in Belgium, contributing to the development of biomanufacturing solutions for monoclonal antibodies and viral vector production systems. He also led project management activities for the technology transfer of insulin and monoclonal antibody fill-and-finish manufacturing operations in Saudi Arabia. His experience spans drug substance and drug product bioprocesses, pharmaceutical facility design, technology transfer, and the delivery of complex pharmaceutical projects. Having built his career across Europe and the Middle East, he brings an international perspective that is well suited to supporting clients in the region's fast-evolving pharmaceutical landscape. Mohammed holds an MSc in Biochemical Engineering from University College London (UCL) and an Executive MBA from Vlerick Business School, specializing in AI and Digital Transformation, where his thesis explored the application of AI in biopharmaceutical engineering. At DUPHAT 2026, he will present on the digital transformation journey and use of AI in GxP environments to strengthen quality, efficiency, and regulatory trust in pharma productio

Dr. Mohammed Sharawy

General Manager | United Arab Emirates

.

Prof. Nabil Zary

Senior Director Professor - Medical Education HQ - Institute of Learning Dept | United Arab Emirates

Professor Nabil Zary serves as the Senior Director of the Institute of Learning at Dubai Health and is a Professor of Medical Education at Mohammed Bin Rashid University of Medicine and Health Sciences in Dubai. He studied medicine and earned his doctorate in medical sciences from the Karolinska Institute in Sweden. His research primarily focuses on artificial intelligence, learning health systems, medical education, and new technologies in health professions education. He is well known for his work on AI in medical education and leads initiatives that support health professionals in engaging with AI in practical, ethical, and forward-looking ways.

Dr. Nadia Al Mazroui

PhD, MSc, F-FIP | United Arab Emirates

Vice President, International Pharmaceutical Federation (FIP) | Fellow, FIP President, Pharmacists Association – UAE | Associate Professor, University of Sharjah

Dr. Nadine Z. Zeinab

Pharm. M.Sc. Chief Pharmacist at Emirates Specialty Hospital, DHCC. | United Arab Emirates

Ms. Zeinab is the Chief Pharmacist at Emirates Specialty Hospital, DHCC. She Leads the operational and clinical pharmacy excellence, strategic goals, regulatory governance of the pharmacy department ensuring safe, effective, and evidence-based medication management across the hospital. Adopts innovation and implements pharmacy practice improvements that ensure staff development and align with the hospital’s strategic goals, international, and national regulatory standards. She implements a structured medication safety program to minimize adverse drug events and optimize patient outcomes.With more than 15 years of experience in Pharmacy practice Ms. Zeinab is passionate about redefining the role of pharmacists in healthcare and bridging the gap between theory and real-world practice. Previously, Ms. Zeinab held key leadership roles as an Oncology Pharmacy Consultant and Pharmacy Practice Improvement Specialist at Clemenceau Medical Center Lebanon affiliated with Johns Hopkins Medicine International, Pharmacy Manager at Clemenceau Medical Centre Hospital in Dubai and Oncology Pharmacy Unit Manager/ Pain and Palliative Pharmacist at Clemenceau Medical Centre Lebanon. In these positions, she contributed significantly to the development of clinical pharmacy services, policies and procedures, accreditation preparation, team development, outpatient pharmacy service improvement, oncology pharmacy service establishment, and pain/palliative pharmacy service development. Ms. Zeinab has diverse pharmacy experience and holds multiple certifications in oncology pharmacy practice (both adult and pediatric), medication safety, international clinical pharmacy skills, pain management, palliative care, clean compounding techniques, pharmacy consultant, and healthcare quality. Ms. Zeinab is affiliated with the European Society of Oncology Pharmacy (ESOP) as a certified ESOP trainer and a member of the European Specialization in Oncology Pharmacy (EUSOP), contributing to the development and recording of several lectures in the European oncology pharmacy certification program.

Dr. Omar Sulaiman

BCCCP , RCP Pharm D Critical care Clinical Pharmacist Head of clinical pharmacy services- KHUH" | Bahrain

Dr Omar sulaiman omar Abudulaziz, critical care clinical pharmacologist in king Hamad university Hospital – RMS, American board certified in critical care BCCCP ,received the Doctor of Pharmacy degree on 2017 From university of jordan, Head of clinical pharmacy services in king hamad university hospital (RMS) a member of the National quality and clinical committee in the supreme council of health and member of the British and National Antimicrobial stewardship committee (BSAC) board member of bahrain pharmacist society NHRA surveyor "

Dr. Rama Nasef

Pharm.D, BCIDP, Senior infectious disease clinical pharmacis | United Arab Emirates

She is a board certified infectious diseases pharmacist (BCIDP) with 10 years of clinical and stewardship experience. She earned her Doctor of Pharmacy in 2015. Worked in Cleveland clinic Abu Dhabi as a clinical staff pharmacist from 2015 to 2025. Currently serving as Senior Infectious Disease clinical Specialist at Dubai Health, she co-chairs the Central Antimicrobial Stewardship Program (ASP) across Dubai Health and Rashid Hospital and a member in the national ASP committee Rama is a recognized leader in antimicrobial stewardship, with multiple publications in peer-reviewed journals, abstracts and presentations in the field of infectious disease. She has played a pivotal role in establishing Dubai Health’s ASP framework, developing evidence based guidelines, and optimizing protocols for adult. Her work spans Epic system builds, and strategic stewardship reporting for executive leadership

Ms. Rasha Wahdan

BSc Pharm, BCPS, BCIDP, MB | United Arab Emirates

Senior Clinical Pharmacist | Antimicrobial Stewardship & Infectious Diseases Leader | UAE Delegate, ESOP

Prof. Reza Karimi

Professor | USA

Dr. Reza Karimi is a licensed pharmacist and preceptor in the state of Oregon, with more than 20 years of academic experience in pharmacy education. He joined the academia in 2002 as a faculty member and has assumed various leadership positions, including Director, Assistant Dean, Associate Dean, and Dean. Currently, he serves as a Professor of Pharmacy Practice to teach pharmacy students at Pacific University School of Pharmacy. His teaching expertise is in biochemistry and pharmacotherapy and his research spans pharmacy practice, biomedical & clinical sciences, and educational research and outcomes. He is an avid advocate for the profession of pharmacy, both in the U.S. and around the world, and is committed to equity, diversity, and inclusion. He has served on the ACPE Board of Directors (2018-2024, including as President in 2022). Dr. Karimi’s extensive body of work includes 31 peer-reviewed publications, 11 book chapters, and served as editor for a pharmacy textbook: Biomedical & Pharmaceutical Sciences: with patient care correlations. He received his MSc (Pharmacy) in 1991 and his PhD (Molecular Biology) in 1998 from Uppsala University, Sweden and completed a 3-year postdoctoral training at the University of Nevada, Reno, USA in 2002.

Dr. Rima Abdallah

BDS, CAGS, DSc, Consultant Periodontist | Implantologist Chief | United Arab Emirates

Board-certified Consultant Periodontist and Implantologist with over 17 years of clinical experience, including 12 years in Periodontology and Implant Dentistry and 11 years in academic dentistry. Currently serving as Chief of the American Hospital Dental Institute, providing leadership in advanced periodontal care, implant surgery, interdisciplinary treatment planning, clinical governance, and postgraduate education. International speaker, published researcher, Diplomate of the American Board of Periodontology, and Fellow of the International College of Dentists with extensive experience in evidence-based clinical practice.

Dr. Ruqaya Al Bastaki

Ruqaya Al Bastaki · 3rd Director of Drug Department | United Arab Emirates

Director of Drug Department, Ministry of Health and Prevention. 23 years of remarkable experience in pharmaceutical diversed field varying from procurement to pharmaceutical regulatory aspects. Outstanding leader dedicated to overseeing the complex landscape of medical product registration in the UAE, achieving high level of fast track innovator medicine registration in the Middle East and Mena region. Supervising medical products import/export activities and the enforcement of controlled substance regulations. Committed to ensuring the highest standards of product quality control analysis contributing to the well-being of the community and the growth of the healthcare sector in the UAE and beyond. A catalyst for remarkable digital transformation, enhancing electronic services to streamline operations and improve efficiency. Robust records in enhancing performace of medical products manufacturing facilities, and international relations.

Dr. Saad Kanaan

Consultant Neurologist and Headache Specialist | United Arab Emirates

MBBS is a board-certified neurologist and headache medicine specialist with more than a decade of experience in clinical neurology, headache disorders, stroke care, and academic medicine. He currently serves as Consultant Neurologist and Headache Specialist at Emirates Hospital Jumeirah, Dubai (since September 2025). Prior to joining Emirates Hospital, Dr. Kanaan practiced as a Staff Neurologist and Headache Specialist at Premier Health, Ohio (2022–2025) and was an Assistant Professor of Neurology at the University of Cincinnati Physicians (2020–2022). He also completed a prestigious Headache Medicine Fellowship at Harvard Medical School, Brigham and Women’s Hospital, and Massachusetts General Hospital, subsequently serving as a staff neurologist within the Harvard system. Earlier in his career, he worked as a neurologist and Stroke Medical Director at Via Christi Hospitals in Kansas, where he led the development of a Comprehensive Stroke Center and multiple stroke quality initiatives. Dr. Kanaan earned his MBBS from Jordan University of Science and Technology and completed his neurology residency at the University of Oklahoma Health Sciences Center. He holds board certification from the American Board of Psychiatry and Neurology and subspecialty certification in Headache Medicine from the United Council for Neurologic Subspecialties. His clinical expertise includes migraine and headache disorders, stroke, multiple sclerosis, neurovascular diseases, and general neurology. He has served as a principal investigator and sub-investigator in numerous clinical trials involving migraine, multiple sclerosis, Alzheimer’s disease, and rare neurological disorders. Dr. Kanaan has authored peer-reviewed publications, contributed a chapter to the Oxford University Press textbook Pain Medicine: Headache, and has delivered numerous national and international presentations on headache medicine and stroke care. An active member of the American Headache Society and the American Academy of Neurology, Dr. Kanaan is recognized for his leadership in neurological care, research, medical education, and healthcare quality improvement.

Dr. Saeed Abdulla

Clinical Assistant Professor | United Arab Emirates

Dr. Saeed Abdulla is a highly experienced clinical pharmacist with over 26 years of practice across both inpatient and outpatient healthcare settings. He earned his Bachelor’s degree in Pharmacy and Master’s degree in Clinical Pharmacy from Ajman University, and further expanded his expertise with a Master’s degree in Public Administration from the Mohammed Bin Rashid School of Government. He also holds a Ph.D. in Healthcare Management from Hamdan Bin Mohammed Smart University. Dr. Saeed is a board-certified pharmacist in Oncology, Pharmacotherapy, Intensive Care, and Infectious Diseases. Throughout his career, he has contributed significantly to advancing clinical pharmacy practice, including serving as Co-Chair of the Antimicrobial Stewardship Program at Zayed Military Hospital. His clinical and research interests focus on infectious diseases and intensive care, with particular emphasis on HIV management, antimicrobial resistance, and substance use disorders. He has co-authored several peer-reviewed publications and is a frequent speaker at national and international pharmaceutical and medical conferences. In addition to his clinical and academic achievements, Dr. Saeed is the Founder and President of the Clinical Pharmacy Society. He currently serves as Clinical Assistant Professor at Ajman University. Dr Saeed was the Head of Pharmacy at the Erada Center for Treatment and Rehabilitation in Dubai from January 2023 to August 2026.

Dr. Sameer Alzaidi

PharmD. MBAc, BCPS, BCIDP, AAHIVP | Saudi Arabia

Dr. Alzaidi completed his doctorate of pharmacy from Ohio Northern University, USA, in 2021. He then pursued a PGY1 and graduated in 2022 from Tufts Medicine Hospital, Boston. During his PGY1, Dr. Alzaidi fell in love with infectious diseases (ID) and decided to pursue a PGY2 at one of the largest healthcare systems in the United States, Intermountain Health. He is American board certified in pharmacotherapy and infectious diseases and hold a board certification in HIV from American Academy of HIV Medicine. He’s currently practicing as a consultant ID clinical pharmacist at Taif Health Cluster, SA. He is the head of IRB and clinical pharmacy Committees at Taif Health Cluster. His ID interests lie on PK/PD, MDROs, and immunocompromised population. He loves fungi and thinks it’s the most under-appreciated kingdom on earth.

Dr. Sameh Elbagoury

Head of Sandoz Saudi Arabia and Gulf (GCC) | Saudi Arabia

Head of Sandoz Saudi Arabia and Gulf (GCC), bringing over 20 years of experience in the pharmaceutical industry across emerging and developed markets. He previously served as Country Head of Sandoz Egypt & Libya since 2019, where he led operations and reinforced the company’s global leadership in off-patent medicines and biosimilars

Prof. Sameh Soliman

Professor | United Arab Emirates

.

Dr. Sara Saad

BMT and Hematology/Oncology Pharmacotherapy Specialist | United Arab Emirates

Sara Saad is a BMT and Hematology/Oncology Pharmacotherapy Specialist at Cleveland Clinic Abu Dhabi (CCAD). She earned her Doctor of Pharmacy degree from Northeastern University in Boston, Massachusetts, USA and completed her residency training at Brigham and Women’s Hospital. Prior to joining CCAD, she served as a Senior BMT/CAR-T and Hematology/Oncology Pharmacist at Brigham and Women’s Hospital and Dana-Farber Cancer Institute, where she gained extensive experience in the management of complex cancer care. At CCAD, she leads initiatives to advance hematology/oncology services and works collaboratively with the multidisciplinary cancer care team to enhance the quality, safety, and delivery of oncology care.

Dr. Shaikha Almazrouei

Head of Quality Control | United Arab Emirates

.

Dr. Sherif Kamal

ESOP Global Ambassador for the Middle East Region | Egypt

"Sherif Kamal is one of a second generation Egyptian clinical pharmacists, with more than 20 years of experience in this field, involved in the planning, designing and implementation of pharmaceutical care in oncology centers and hospitals as senior Clinical Pharmacy consultant. Sherif Kamal is the Advisor of the Chairman of EHA board for medication management and pharmacy affairs He earned his BS in Pharmacy 1998, an MSc in Clinical Pharmacy and is currently a PhD candidate at the Cairo University School of Pharmacy. Sherif has also completed a visiting fellowship at St. Jude’s Children Hospital in the United States in 2008. He is a certified Professional trainer by the AUC and made a healthcare management diploma in AUC with the thesis title :Pharmacy Digitalization - Drug Information and Pharmacy Resource Services For more than 20 years, Sherif has led a team that implemented clinical pharmacy services at various hospitals throughout Egypt and the region . He is the recipient the Egyptian Hospital Pharmacist Association Award and founder of the Egyptian Association of Clinical Pharmacists in 2010 He is a member of several international organizations including the International Society for Oncology Pharmacists, the European Society of Clinical Pharmacy, the American Society of Health-System Pharmacist, and the American College of Pharmacy. He is the Vize President of the European Society of Oncology Pharmacy Global for all Non-European countries. He is a member of the Board for International Accreditation of Hospital Pharmacy in ASHP He has conducted a wide variety of research studies involving the pharmacotherapeutics management of pediatric oncology diseases and presented his work at international meetings. Sherif is working with university of Colorado , American Society of Health system pharmacist ,American college of clinical Pharmacy ,American council for Pharmacy Education and European society if oncology Pharmacy to develop the pharmacy academy program for the health sciences Academy . We started Pharm D program, Residency program and many short courses. The program also introduced successfully the future of pharmacy which Is pharmacogenomics and personalized medication management. Sherif was the leading consultant working to implement clinical pharmacy in Egypt(4 Ministry of health Hoapitals;2 Military Hospitals and 3 Police Hospitals ) . Sherif is also leading an African initiative to improve healthcare via clinical pharmacy and medication management in Africa ,including Sudan,Ethiopia,Malawi , Uganda and Botswana. He was the first International Residency program director in the region and the first Pharm D program director in collaboration with Colrado run by a Hospital. His primary research interest focuses on pharmacy practice, patient safety, pharmacogentics, Pharmacoeconomics, pharmacovigilance , Green Pharmacy and the pharmaco-epidemiology of pediatric cancer. Sherif is also a professionally and practically qualified project manager in fundraising and business development, with more than 20 years of experience in this field, involved in the fundraising activity of the National Cancer Institute and Children's Cancer Hospital Foundation 57357. He is a Certified Lean Six Sigma Green Belt "

Dr. Sherry N. Nasralla

Lecturer, Pharmacy Program College of Health and Sport Sciences University of Bahrain | Bahrain

Ms. Sherry Nasralla is a lecturer at the Pharmacy Program, College of Health and Sport Sciences, University of Bahrain. She holds an M.Sc. in Pharmaceutical Sciences from Ain Shams University, Cairo Egypt; specializing in Pharmacology and Toxicology. Ms. Sherry has 20 years of undergraduate teaching experience and is a Fellow of Advance HE, UK. She has published several research articles in peer reviewed journals, as well as poster and oral presentations at various conferences. Her areas of research interest include pharmacy practice, education and workforce development.

Dr. Sultana Bin Haidar

Head of Quality Control Laboratory for Medical Products | | United Arab Emirates

Head of Quality Control Laboratory for Medical Products | Government Inspector, EDE | Former Youth Council Member, MOHAP

Dr. Tanja Elisabeth Rohark

CEO&Founder | United Arab Emirates

Shaping Diamonds in Global Regulatory Intelligence and Digital Transformation - CH & UAE | Pharma, MedTech, BioTech, HealthCare | Digital Health, Pharma 4.0, Smart Manufacturing & Labs

Dr. Vala Barzinji

Senior Specialist Pharmacist | United Arab Emirates

He is a Senior Specialist Pharmacist at Dubai Health and an Independent Prescribing Pharmacist with over 10 years of international clinical pharmacy experience spanning the UK’s National Health Service (NHS), private healthcare, and the UAE. She is recognized for her expertise in clinical pharmacy, antimicrobial stewardship, medication safety, medicines optimization, and healthcare quality improvement. She has led numerous strategic clinical initiatives that have strengthened medication governance, informed formulary and policy decisions, and advanced evidence-based pharmacy practice across healthcare settings’

Dr. Wadha Abdulrahman

MSc.,Clinical Ph., BCPS, BPharm,Precision and personalized medicine section head. | United Arab Emirates

Bachelor of Pharmacy from Fatima College. Wadha joined SKMC as an Outpatient pharmacist before joining the clinical pharmacy residency program. After completion of residency, Wadha worked as a clinical pharmacist for 3 years, covering internal medicine, pediatric intensive care unit and serving a vital role in the COVID-19 intensive care unit during the pandemic where she assisted physicians with the selection of drug therapy and medication management. Wadha received her Master of Social Sciences Research for Healthcare from Bradford university. Wadha joined the DOH Health Life Sciences Sector in 2022, as a Toxicology and Medication Education Specialist for 1 year. Wadha is currently part of the genome team within the DOH, where she has been instrumental in advancing precision medicine initiatives in Abu Dhabi such as the premarital genetic testing, pharmacogenomic and oncology flagship program.

Dr. Wael Ahmed Eltayeb Osman

Dept. of Internal Medicine, | United Arab Emirates

Dr Wael Ahmed Eltayeb Osman is a Senior Consultant Pulmonologist at University Hospital Sharjah and an Adjunct Clinical Assistant Professor at the University of Sharjah Medical School. He completed his UK clinical training in Respiratory and General Internal Medicine and accumulated 16 years of clinical experience in the United Kingdom before relocating to the UAE four years ago. Dr Osman is a Fellow of the Royal College of Physicians of Edinburgh (RCPE) and the Royal College of Physicians and Surgeons of Glasgow (RCPSG). During his time in the UK, he was actively involved in asthma research, with particular focus on bronchial challenge models aimed at identifying novel inflammatory pathways. He contributed to multiple clinical trials, including Phase III studies involving patients with asthma and chronic obstructive pulmonary disease (COPD). In addition, he has presented abstracts at national and international respiratory conferences and has contributed to several pulmonology research projects. His primary clinical interests include chronic airway disease management, particularly asthma and COPD. Dr Osman advocates a holistic, precision-based approach to diagnosis and management, emphasising phenotype-directed and targeted therapies aimed at preventing disease progression, reducing exacerbations, and improving long-term outcomes. He also has a strong interest in physician and patient education, recognising its vital role in optimising disease control, improving adherence, reducing exacerbation risk, and empowering patients to actively participate in long-term respiratory disease management.

Dr. Wael Alnaeem

Pharmacy Manager,B.Pharm, MSc, PGDCR, RPh | United Arab Emirates

Waiel Al Naeem is the pharmacy manager at SKMC with MSc in Clinical Pharmacy from college of medicine, Sultan Qaboos University, Oman 2004. He worked in Oman as Clinical pharmacist 2004-2008 and then Joined SKMC as a clinical pharmacist. Waiel is a board certified pharmacotherapy specialist providing clinical pharmacy services to kidney transplant patients in SKMC. Waiel is the formulary manager in SKMC and a member of SKMC IRB, SKMC PTC and SEHA PTC. In 2017, Waiel was elected as the Vice Chair for the SKMC PTC. Waiel is an active participant in the continuous pharmacy education programs. In February 2020 Waiel was selected as Director for the SEHA Pharmacy Residency Program. He is also chairing SEHA Pharmacy Continuous Education & Research Subcommittee. Throughout his career, Waiel received many awards in recognition of his efforts in the clinical pharmacy practice

Dr. Wael Ali

President of the FIP Eastern Mediterranean Regional Pharmaceutical Forum (EMRpharm-FIP) for the 2025–2029 term and a member of the Executive Committee of the FIP Community Pharmacy Section | Egypt

"Dr. Wael K. Ali Ali Mazrouh is the President of the FIP Eastern Mediterranean Regional Pharmaceutical Forum (EMRpharm-FIP) for the 2025–2029 term and a member of the Executive Committee of the FIP Community Pharmacy Section (CPS). He also serves as the President of the Egyptian Organization of Pharmacy (EOP) and the President of PharmaHelp Foundation USA, a nonprofit public health research federation based in Virginia. With more than 24 years of experience in pharmacy, healthcare systems, and public health, Dr. Wael is recognized as a visionary leader in pharmacy transformation, education reform, and professional excellence. He has served as a speaker, moderator, and panelist at over 65 international conferences, summits, and workshops, addressing topics such as public health literacy, sustainability, and workforce development. He has co-authored major FIP publications, including “Improving Access to Safe and Quality Essential Medicines and Medical Devices” (2024) and “From Theory to Therapy: Balancing Evidence in Managing Common Ailments” (2025). Dr. Wael is currently pursuing two doctoral degrees a Doctor of Public Health (DrPH) at the American College of Education (USA) and a Doctorate in Business Administration (DBA) at the Arab Academy for Science, financial, and banking. He previously earned a Master of Business Administration (MBA) with distinction and a Master of Public Health (MPH) from the United States, both with honors. Recipient of more than 25 national and international awards, including the FIP Champion Award (2022) and the African Pharmaceutical Forum Award (2024), Dr. Wael continues to promote innovation, collaboration, and excellence in pharmacy education and practice across the Eastern Mediterranean Region and beyond.

Dr. Yanal Salam

HOD & Consultant Internal Medicine | United Arab Emirates

.

Dr. Yousuf Jamjoom

CEO | Saudi Arabia

Keen believer of the intersection between technology & pharma! Jeddah, Makkah, Saudi Arabia